Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library
|
November 6, 2007
TRAIL and osteoprotegerin: a role in endothelial physiopathology?
Federica Corallini, Erika Rimondi, Paola Secchiero
Anatomical Record (Hoboken, N.J. : 2007)
|
May 17, 2007
Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts
Erika Rimondi, Marina Zweyer, Enrico Ricci, et al.
Investigational New Drugs
|
February 5, 2010
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines
Claudio Celeghini, Rebecca Voltan, Erika Rimondi, et al.
Investigational New Drugs
|
November 17, 2012
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1
Erika Rimondi, Paola Secchiero, Elisabetta Melloni, et al.
Journal of Cellular Physiology
|
October 31, 2009
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL)
Giorgio Zauli, Erika Rimondi, Claudio Celeghini, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
June 19, 2018
Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema
Mirko Tessari, Veronica Tisato, Erika Rimondi, et al.
American Journal of Ophthalmology
|
April 6, 2019
Factors Predictive of Double Anterior Chamber Formation Following Deep Anterior Lamellar Keratoplasty
James Myerscough, Cristina Bovone, Michael Mimouni, et al.
International Journal of Molecular Sciences
|
May 5, 2021
MitoQ Is Able to Modulate Apoptosis and Inflammation
Elisa Piscianz, Alessandra Tesser, Erika Rimondi, et al.
Blood
|
June 24, 2004
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF
Giorgio Zauli, Erika Rimondi, Vanessa Nicolin, et al.
Journal of Experimental Pharmacology
|
September 10, 2025
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide
Erika Rimondi, Elisabetta Melloni, Paola Secchiero, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Frontiers in Bioscience : a Journal and Virtual Library
|
November 6, 2007
TRAIL and osteoprotegerin: a role in endothelial physiopathology?
Federica Corallini, Erika Rimondi, Paola Secchiero
Anatomical Record (Hoboken, N.J. : 2007)
|
May 17, 2007
Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts
Erika Rimondi, Marina Zweyer, Enrico Ricci, et al.
Investigational New Drugs
|
February 5, 2010
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines
Claudio Celeghini, Rebecca Voltan, Erika Rimondi, et al.
Investigational New Drugs
|
November 17, 2012
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1
Erika Rimondi, Paola Secchiero, Elisabetta Melloni, et al.
Journal of Cellular Physiology
|
October 31, 2009
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL)
Giorgio Zauli, Erika Rimondi, Claudio Celeghini, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders
|
June 19, 2018
Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema
Mirko Tessari, Veronica Tisato, Erika Rimondi, et al.
American Journal of Ophthalmology
|
April 6, 2019
Factors Predictive of Double Anterior Chamber Formation Following Deep Anterior Lamellar Keratoplasty
James Myerscough, Cristina Bovone, Michael Mimouni, et al.
International Journal of Molecular Sciences
|
May 5, 2021
MitoQ Is Able to Modulate Apoptosis and Inflammation
Elisa Piscianz, Alessandra Tesser, Erika Rimondi, et al.
Blood
|
June 24, 2004
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF
Giorgio Zauli, Erika Rimondi, Vanessa Nicolin, et al.
Journal of Experimental Pharmacology
|
September 10, 2025
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide
Erika Rimondi, Elisabetta Melloni, Paola Secchiero, et al.
Page
of 7